« Back to Record
Sotiriou, C., Rothé, F., Maetens, M. M., Fumagalli, D., Brown, D. N., Salgado, R., Bradbury, I., Puztai, L., Harbeck, N., Ignatiadis, M., Sarp, S., de la Peña, L., de Azambuja, E., Huober, J., Nuciforo, P., Baselga, J., Piccart-Gebhart, M., Loi, S., & Venet, D. (2017). Copy number aberration analysis to predict response to neoadjuvant anti-HER2 therapy: Results from the NeoALTTO phase III trial. SABCS Abstracts2View™ Portal Abstract session presented at 40th San Antonio Breast Cancer Symposium(40: 05-09/12/2017: San Antonio)
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/265779



